Public Profile

ChromaDex

ChromaDex Corporation, a leading player in the nutraceutical and dietary supplement industry, is headquartered in the United States. Founded in 2009, the company has established itself as a pioneer in the development and commercialisation of innovative ingredients and products that support health and wellness. ChromaDex is renowned for its flagship product, TRU Niagen®, a patented form of nicotinamide riboside that promotes cellular health and energy metabolism. This unique offering has positioned the company at the forefront of the burgeoning market for NAD+ precursors, appealing to health-conscious consumers and researchers alike. With a commitment to scientific research and quality, ChromaDex has achieved significant milestones, including partnerships with major brands and recognition for its contributions to the field of nutritional science. As it continues to expand its operational reach, ChromaDex remains dedicated to enhancing the understanding of cellular health and the role of dietary supplements in overall well-being.

DitchCarbon Score

How does ChromaDex's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

ChromaDex's score of 25 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

38%

Let us know if this data was useful to you

ChromaDex's reported carbon emissions

ChromaDex, headquartered in the US, currently does not have publicly available carbon emissions data for recent years, as indicated by the absence of specific figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This lack of data suggests that ChromaDex may still be in the early stages of formalising its climate commitments or reporting its emissions. As the industry increasingly prioritises sustainability, it will be essential for ChromaDex to establish clear targets and strategies to address its carbon footprint and contribute to broader climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. ChromaDex's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for ChromaDex is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

ChromaDex is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Eurofins Scientific

LU
Other business services (74)
Updated about 11 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers